Nova Leap Health Corp. NLH.V
TSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 19.53% | 21.95% | 22.15% | 16.47% | 8.63% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 19.53% | 21.95% | 22.15% | 16.47% | 8.63% |
| Cost of Revenue | 17.98% | 19.50% | 19.59% | 14.69% | 7.34% |
| Gross Profit | 21.94% | 25.84% | 26.27% | 19.32% | 10.70% |
| SG&A Expenses | 15.75% | 21.68% | 24.95% | 19.79% | 13.90% |
| Depreciation & Amortization | 7.81% | 24.56% | 42.70% | 25.98% | 2.46% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 16.95% | 20.37% | 21.95% | 16.69% | 9.39% |
| Operating Income | 101.94% | 75.76% | 28.07% | 10.93% | -11.02% |
| Income Before Tax | 569.18% | -66.00% | -107.28% | 311.09% | 71.03% |
| Income Tax Expenses | 217.22% | -46.42% | -86.67% | 1,610.34% | 339.02% |
| Earnings from Continuing Operations | 1,060.29% | -74.24% | -113.77% | 262.21% | -7.71% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 1,060.29% | -74.24% | -113.77% | 262.21% | -7.71% |
| EBIT | 101.94% | 75.76% | 28.07% | 10.93% | -11.02% |
| EBITDA | 63.20% | 56.13% | 36.41% | 15.99% | -7.05% |
| EPS Basic | 710.53% | -75.00% | -112.88% | 267.27% | 46.15% |
| Normalized Basic EPS | 208.89% | -68.47% | -100.00% | 55.93% | -53.13% |
| EPS Diluted | 1,775.00% | -78.72% | -117.53% | 237.29% | 60.00% |
| Normalized Diluted EPS | 220.93% | -67.89% | -100.00% | 52.54% | -55.21% |
| Average Basic Shares Outstanding | 2.53% | 2.46% | 2.46% | -0.66% | -0.98% |
| Average Diluted Shares Outstanding | 2.64% | 2.31% | 2.10% | 0.05% | -0.74% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |